Madison Dearborn Partners to acquire Alcami
Submitted by:
Andrew Warmington
Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biotechnology
DCAT awards scholarships for astonishing student projects
Submitted by:
Andrew Warmington
The Drug, Chemical & Associated Technologies Association (DCAT) has announced the winners of four scholarships
CPhI: Science fiction and innovation
Submitted by:
Andrew Warmington
This year’s InformEx/CPhI North America event was buzzing, with thousands of attendees and over 25
There are two fundamental questions in healthcare, Leist said: “Did the patient take their medicine
AkzoNobel to sell speciality chemicals business for €10 billion
Submitted by:
Andrew Warmington
Paints, coatings and speciality chemicals multinational AkzoNobel has announced the sale of its entire speciality chemicals
Evonik and Siemens join up to produce 'green' speciality chemicals
Submitted by:
Andrew Warmington
Chemicals company Evonik and electronics giant Siemens have launched a joint research project to convert
EU clears way for Bayer, Monsanto mega-merger
Submitted by:
Andrew Warmington
Agrichemical giant Bayer has won EU antitrust approval for its US$62.5 billion acquisition of Monsanto,
Lonza cuts ribbon on world’s largest cell and gene therapy facility
Submitted by:
Andrew Warmington
Lonza has opened the world’s largest dedicated cell and gene therapy manufacturing facility in Houston, Texas
2nd Annual Highly Potent Active Pharmaceutical Ingredients conference
Submitted by:
Andrew Warmington
The global market for highly potent active pharmaceutical ingredients is currently on a growth fast
CPhI South East Asia to open Thailand event in 2019
Submitted by:
Andrew Warmington
From 2019, CPhI South East Asia – organised by UBM – has announced it will
DCAT: From the podium
Submitted by:
Andrew Warmington
With over 10,000 industry professional attendees, this year’s DCAT Week, held from 19-23 March in
Meanwhile, last year was the “best” for chemicals and biotechnology company Lonza, which last year
In one of the industry's speeder acquisitions, CordenPharma acquired a Pfizer site in Boulder Colorado
Some interesting things are happening. Small companies (outside the top 50) are accounting for more